Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Even after more than 50 MMPl-icenses we still have the same share price trouble

Had they not paid the dividends they might have put that much more cash into ARS; we might be in a similar position.

Aside; we have had about 5 or 6 licenses in 5 or 6 weeks and, since we can only infer, perhaps the trend is indicative of the behind-the-scenes actions related to the 336 et.al. and hopefully the notion that licensees see something that tells them they better buy in now. But since that postulation could be completey incorrect and no one knows anything for certain regarding our most valuable and profitable asset, we have .12.

Best









Share
New Message
Please login to post a reply